Translating A Non-Viral Anti-Inflammatory Gene Therapy into ALS Mouse Models & Preparing for First In-Human Studies
Time: 1:10 pm
day: Day Two Track A PM
Details:
- Developing a unique therapeutic approach of targeting IL-10 with a non-viral gene therapy
- Showcasing preclinical data of anti-inflammatory effect in TDP-43 mouse models
- Outlining future directions for translation into phase 1 clinical study
